Home › Funds › RA CAPITAL MANAGEMENT, L.P. › SGP
RA CAPITAL MANAGEMENT, L.P. position in SGP
SPYGLASS PHARMA INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 8,021,117 shares of SGP (SPYGLASS PHARMA INC) in its Q2 2026 13F filing — a position valued at US$178.6M, representing 1.55% of its reported portfolio and ranking #15 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed SGP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s SGP position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in SGP in Q1 2026 at 8,021,117 shares (US$207.8M). Across 2 filings, RA CAPITAL MANAGEMENT, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 8,021,117 shares valued at US$178.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 8.02M | $207.83M | New |
| Q2 2026 | 8.02M | $178.55M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SGP and 13F data
SGP (SPYGLASS PHARMA INC) is a Health Care company. 61 other funds we track also report a position in SGP — the largest reported positions include NEA Management Company, LLC (US$164.6M), Sands Capital Alternatives, LLC (US$55.7M), Samsara BioCapital, LLC (US$47.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGP
- NEA Management Company, LLC 7.39M sh · $164.55M · Q2 2026
- Sands Capital Alternatives, LLC 2.50M sh · $55.65M · Q2 2026
- Samsara BioCapital, LLC 2.11M sh · $46.97M · Q2 2026
- Vestal Point Capital, LP 670.00K sh · $14.91M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held SGP?
RA CAPITAL MANAGEMENT, L.P. has disclosed SGP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in SGP?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 8.02M shares of SGP (SPYGLASS PHARMA INC), valued at $178.55M, representing 1.55% of its reported portfolio and ranking #15.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling SGP?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in SGP.
Which other funds hold SGP?
Other major institutional holders of SGP include NEA Management Company, LLC, Sands Capital Alternatives, LLC, Samsara BioCapital, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.